Sanofi (SNYNF)
92.54
-0.91
(-0.98%)
USD |
OTCM |
Aug 24, 16:00
Sanofi Debt to Equity Ratio
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2014 | 0.264 |
| June 30, 2014 | |
| December 31, 2013 | 0.2564 |
| June 30, 2013 | |
| December 31, 2012 | |
| June 30, 2012 | |
| December 31, 2011 | |
| June 30, 2011 | |
| December 31, 2010 | |
| June 30, 2010 | |
| December 31, 2009 | 0.1832 |
| Date | Value |
|---|---|
| June 30, 2009 | |
| December 31, 2008 | |
| June 30, 2008 | |
| December 31, 2007 | |
| June 30, 2007 | |
| December 31, 2006 | |
| June 30, 2006 | |
| December 31, 2005 | |
| June 30, 2005 | |
| December 31, 2004 | 0.3907 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Ipsen SA | -- |
| AB Science SA | -- |
| MedinCell SA | -- |
| Vétoquinol SA | -- |
| Pfizer Inc. | 0.7418 |